HEMATOPOIETIC SYSTEM
specific21
Centers
0
Active Trials
$35M
Cancer Funding
Top Centers for HEMATOPOIETIC SYSTEM(21)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 69.0 |
| 2 | NCI Comprehensive Active Research Program | 67.4 |
| 3 | NCI Comprehensive Active Research Program | 65.7 |
| 4 | The Jackson Laboratory Cancer CenterBar Harbor, ME NCI Basic_laboratory Active Research Program | 64.0 |
| 5 | NCI Comprehensive Active Research Program | 62.4 |
| 6 | NCI Comprehensive Active Research Program | 60.7 |
| 7 | Duke Cancer InstituteDurham, NC NCI Comprehensive Active Research Program | 59.0 |
| 8 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 57.4 |
| 9 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 55.7 |
| 10 | Mount Sinai Tisch Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 54.0 |
| 11 | NCI Comprehensive Active Research Program | 52.4 |
| 12 | NCI Comprehensive Active Research Program | 50.7 |
| 13 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 49.0 |
| 14 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 47.4 |
| 15 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 45.7 |
| 16 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 44.0 |
| 17 | NCI Comprehensive Active Research Program | 42.4 |
| 18 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 40.7 |
| 19 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 39.0 |
| 20 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 36.5 |
| 21 | University of Illinois Cancer CenterChicago, IL | 36.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →